Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Dietary Supplements × Clear all

NCT07064668 2025-07-15

Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular